ELOVL5 and neoplasm: In the tumor, there was decreased expression of ELOVL5 in the women compared to the peritumoral area (enhancing tumor region—p = 0.015; tumor core—p = 0.005), and an increased expression of ELOVL5 in the men (enhancing tumor region—p = 0.03; tumor core—p = 0.055).